医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
6期
1073-1075
,共3页
张运捷%王镜雯%宋波%何慧君%吴广飞%刘博伟
張運捷%王鏡雯%宋波%何慧君%吳廣飛%劉博偉
장운첩%왕경문%송파%하혜군%오엄비%류박위
糖尿病,2 型%胰岛%氧化性应激%硫辛酸
糖尿病,2 型%胰島%氧化性應激%硫辛痠
당뇨병,2 형%이도%양화성응격%류신산
Diabetes Mellitus,Type 2%Islets of Langerhans%Oxidative Stress%Thioctic Acid
【目的】评价α-硫辛酸对初诊2型糖尿病(T2DM)患者胰岛β细胞功能及氧化应激水平影响。【方法】将2013年3~9月秦皇岛市第一医院的80例初诊T2DM患者随机分为A、B两组,均行胰岛素泵强化治疗2周,A组同时静脉输注α-硫辛酸。治疗前及治疗2周后检测两组患者的血糖、血脂,采用稳态模型(HOMA)计算胰岛β细胞功能指数(HOMA-β),酶联免疫吸附法检测尿8-异前列腺素 F2α(8-isoPGE),评价氧化应激水平。【结果】治疗后,A组 HOMA-β显著高于B组(P<0.05),8-isoPGF分泌率[F2α(8-isoPGE)/Cr]显著低于B组(P<0.05),F2α(8-isoPGE)/Cr与餐后2 h血糖(2hPG)(r=0.432,P<0.01)、总胆固醇(TC)(r =0.315,P <0.01)、体质量指数(BMI)(r =0.256,P <0.05)呈正相关,与 HOMA-β(r =-0.217,P<0.05)呈负相关。2hPG是尿F2α(8-isoPGE)/Cr的独立危险因素。【结论】应用α-硫辛酸可改善初诊T2DM患者胰岛β细胞功能,降低氧化应激水平。
【目的】評價α-硫辛痠對初診2型糖尿病(T2DM)患者胰島β細胞功能及氧化應激水平影響。【方法】將2013年3~9月秦皇島市第一醫院的80例初診T2DM患者隨機分為A、B兩組,均行胰島素泵彊化治療2週,A組同時靜脈輸註α-硫辛痠。治療前及治療2週後檢測兩組患者的血糖、血脂,採用穩態模型(HOMA)計算胰島β細胞功能指數(HOMA-β),酶聯免疫吸附法檢測尿8-異前列腺素 F2α(8-isoPGE),評價氧化應激水平。【結果】治療後,A組 HOMA-β顯著高于B組(P<0.05),8-isoPGF分泌率[F2α(8-isoPGE)/Cr]顯著低于B組(P<0.05),F2α(8-isoPGE)/Cr與餐後2 h血糖(2hPG)(r=0.432,P<0.01)、總膽固醇(TC)(r =0.315,P <0.01)、體質量指數(BMI)(r =0.256,P <0.05)呈正相關,與 HOMA-β(r =-0.217,P<0.05)呈負相關。2hPG是尿F2α(8-isoPGE)/Cr的獨立危險因素。【結論】應用α-硫辛痠可改善初診T2DM患者胰島β細胞功能,降低氧化應激水平。
【목적】평개α-류신산대초진2형당뇨병(T2DM)환자이도β세포공능급양화응격수평영향。【방법】장2013년3~9월진황도시제일의원적80례초진T2DM환자수궤분위A、B량조,균행이도소빙강화치료2주,A조동시정맥수주α-류신산。치료전급치료2주후검측량조환자적혈당、혈지,채용은태모형(HOMA)계산이도β세포공능지수(HOMA-β),매련면역흡부법검측뇨8-이전렬선소 F2α(8-isoPGE),평개양화응격수평。【결과】치료후,A조 HOMA-β현저고우B조(P<0.05),8-isoPGF분비솔[F2α(8-isoPGE)/Cr]현저저우B조(P<0.05),F2α(8-isoPGE)/Cr여찬후2 h혈당(2hPG)(r=0.432,P<0.01)、총담고순(TC)(r =0.315,P <0.01)、체질량지수(BMI)(r =0.256,P <0.05)정정상관,여 HOMA-β(r =-0.217,P<0.05)정부상관。2hPG시뇨F2α(8-isoPGE)/Cr적독립위험인소。【결론】응용α-류신산가개선초진T2DM환자이도β세포공능,강저양화응격수평。
[Obj ective]To evaluate the effect ofα-lipoic acid on islet beta cell function and oxidative stress in patients with new diagnosed type 2 diabetes mellitus(T2DM).[Methods]Totally 80 patients with new di-agnosed T2DM in first hospital of Qinhuangdao city from March 2013 to Sept.2013 were randomly divided in-to group A and group B.All patients were given insulin pump intensification therapy for 2 weeks.Group A was simultaneously treated with intravenous infusion ofα-lipoic acid.Blood glucose and lipids of two groups were measured before and 2 weeks after treatment.Islet beta cell function index(HOMA-β)was calculated by using steady state model(HOMA).Enzyme linked immunosorbent assay was used to detect urine 8-isoprostan-es F2α(8-isoPGE).Oxidative stress was assessed.[Results]After treatment,HOMA-βin group A was higher than that in group B(P<0.05),while urine F2α(8-isoPGE)/Cr in group A was lower than that in group B(P<0.05).F2α(8-isoPGE)/Cr was positively correlated with 2h-postprandial glucose(2hPG)(r=0.432,P<0.01),total cholesterol(TC)(r=0.315,P<0.01)and body mass index(BMI)(r=0.256,P<0.05),but negatively correlated with HOMA-β(r=-0.217,P<0.05).The 2hPG was the independent risk factor of secretory rate of F2α(8-isoPGE)/Cr.[Conclusion]Theα-lipoic acid can improve islet beta cell function and re-duce oxidative stress level of patients with new diagnosed T2DM.